支持性种植周维护治疗对种植体周黏膜炎与种植体周炎疗效的系统评价
该系统评价检索MEDLINE、Embase、Cochrane Library和Web of Science至2025年4月30日,纳入9项随机对照试验、13项队列研究和3项病例对照研究,共25项研究。结果显示,个体化、基于风险的回访间隔的支持性种植周维护治疗(SPiT)在探诊深度和探诊出血等临床指标上持续优于标准或无非支持性维护,但研究间异质性大,辅助治疗和患者依从性差异显著。结论推荐将基于风险的SPiT方案整合到常规种植维护中,以改善临床结局和种植体存留率。
要点
- 基于风险个体化回访间隔的SPiT可改善探诊深度和探诊出血。
- SPiT效果优于标准固定间隔维护或无非支持性维护。
- 临床应依据牙周炎史、吸烟和全身健康定制回访与辅助措施。
核心结论
- 个体化、基于风险的SPiT方案较标准固定间隔维护或无非支持性治疗能显著改善临床结局和种植体存留率。
研究设计与样本
- 系统评价检索MEDLINE、Embase、Cochrane Library和Web of Science至2025年4月30日。
- 纳入25项研究:9项随机对照试验、13项队列研究、3项病例对照研究。
- 采用Cochrane ROB 2.0和Newcastle-Ottawa量表评估偏倚风险,因异质性大采用叙述性综合。
主要发现
- SPiT尤其是个体化、基于风险的回访间隔,在探诊深度和探诊出血等临床指标上持续改善。
- 辅助治疗、患者依从性和全身合并症报告方面存在较大变异。
- 研究间临床和方法学异质性高,限制明确结论和普遍性。
临床怎么用
- 将基于风险的SPiT方案整合到常规种植维护中,以改善临床结局并减少疾病进展。
- 根据患者特异性风险因素(包括牙周炎史、吸烟状况和全身健康)定制回访间隔和辅助措施。
- 采用个体化SPiT方案可提高种植体存留率并减少并发症。
局限性
- 研究间临床和方法学异质性高,限制明确结论。
- 全身状况记录不一致。
- 辅助治疗存在变异性,限制普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peri-implant mucositis and peri-implantitis are increasingly prevalent, necessitating evidence-based maintenance strategies. Supportive peri-implant therapy (SPiT) protocols are proposed to limit disease progression and enhance clinical outcomes, yet their effectiveness remains variably reported. The authors aimed to systematically evaluate the effectiveness of SPiT protocols in preventing or reducing the progression of peri-implant diseases, with a primary focus on radiographic bone loss, clinical parameters, and patient-reported outcomes. TYPES OF STUDIES REVIEWED: A comprehensive systematic search was conducted in MEDLINE, Embase, Cochrane Library, and Web of Science through April 30, 2025. Eligible studies included randomized controlled trials, cohort studies, and case-control studies assessing professionally delivered SPiT. Risk of bias was assessed using the Cochrane of risk of bias tool for randomized trials ROB 2.0 and the Newcastle-Ottawa Scale for observational studies. Due to considerable clinical and methodological heterogeneity, results were synthesized narratively. RESULTS: Twenty-five studies met inclusion criteria: 9 randomized controlled trials, 13 cohort studies, and 3 case-control studies. SPiT, particularly with individualized, risk-based recall intervals, consistently improved clinical outcomes, such as probing depth and bleeding on probing compared with standard or no maintenance. However, substantial variability existed regarding adjunctive therapies, patient compliance, and reporting of systemic comorbidities. High clinical and methodological heterogeneity among studies, inconsistent documentation of systemic conditions, and variability in adjunctive therapies limited definitive conclusions and generalizability. CONCLUSIONS AND PRACTICAL IMPLICATIONS: Individualized risk-based SPiT protocols substantially enhance clinical outcomes and implant longevity compared with standard fixed-interval maintenance or no supportive therapy. Future research should standardize reporting, better account for patient-specific risk factors, and clarify the long-term effectiveness of adjunctive therapies. Risk-based SPiT protocols should be integrated into routine implant maintenance to improve clinical outcomes and reduce disease progression. Clinicians are encouraged to tailor recall intervals and adjunctive measures on the basis of patient-specific risk factors, including history of periodontitis, smoking status, and systemic health. Adopting individualized SPiT protocols can enhance implant longevity and minimize complications.
引用
- Mojaver S, Zad A, Sarmiento H, et al. Efficacy of supportive peri-implant therapy in the management of peri-implant mucositis and peri-implantitis: A systematic review. J Am Dent Assoc. 2025. PMID: 41204923. doi:10.1016/j.adaj.2025.08.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。